Marc Stecker @Wheelchair Kamikaze comments and details the trials on the new approved drug "Ocrevus: Leading MS Clinic Issues Cautionary Statement"
http://www.wheelchairkamikaze.com/2017/03/leading-ms-clinic-issues-cautionary.html

On March 28, 2017, the new MS drug Ocrevus was approved for both relapsing MS and progressive MS, becoming the first drug to achieve FDA a...